ERBB2 and neoplasm: Patients #9 and #10 both had a HER2‐negative tumour component with a gain of 8q24, which comprised a copy number gain of both MYC and the adjacent long noncoding RNA (lncRNA) plasmacytoma variant translocation 1 (PVT1).